Qianni Cheng, Ph.D.
Affiliations: | 2010 | The Chinese University of Hong Kong, Hong Kong, Hong Kong |
Area:
1. Drug resistant of pathogenic bacteria. 2. Molecular virology of HIV and HBV.Google:
"Qianni Cheng"Mean distance: 23.26 (cluster 18) | S | N | B | C | P |
Parents
Sign in to add mentorSin M. Ng | grad student | 2010 | Chinese University of Hong Kong | |
(Potential Roles of Angiotensin II, Glucagon Like Peptide-1 and Vitamin D Systems in Pancreatic Islet Function.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Zhang D, So WY, Wang Y, et al. (2016) Insulinotropic effects of GPR120 agonists are altered in obese non-diabetic and diabetic states. Clinical Science (London, England : 1979) |
So WY, Cheng Q, Xu A, et al. (2015) Loss of fibroblast growth factor 21 action induces insulin resistance, pancreatic islet hyperplasia and dysfunction in mice. Cell Death & Disease. 6: e1707 |
Chen L, So WY, Li SY, et al. (2015) Niacin-induced hyperglycemia is partially mediated via niacin receptor GPR109a in pancreatic islets. Molecular and Cellular Endocrinology. 404: 56-66 |
So WY, Cheng Q, Chen L, et al. (2013) High glucose represses β-klotho expression and impairs fibroblast growth factor 21 action in mouse pancreatic islets: involvement of peroxisome proliferator-activated receptor γ signaling. Diabetes. 62: 3751-9 |
Leung PS, Cheng Q. (2010) The novel roles of glucagon-like peptide-1, angiotensin II, and vitamin D in islet function. Advances in Experimental Medicine and Biology. 654: 339-61 |
Cheng Q, Law PK, de Gasparo M, et al. (2008) Combination of the dipeptidyl peptidase IV inhibitor LAF237 [(S)-1-[(3-hydroxy-1-adamantyl)ammo]acetyl-2-cyanopyrrolidine] with the angiotensin II type 1 receptor antagonist valsartan [N-(1-oxopentyl)-N-[[2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]methyl]-L-valine] enhances pancreatic islet morphology and function in a mouse model of type 2 diabetes. The Journal of Pharmacology and Experimental Therapeutics. 327: 683-91 |